These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16441775)

  • 1. Sirolimus in de novo heart transplant recipients with severe renal impairment.
    Vazquez de Prada JA; Vilchez FG; Cobo M; Ruisanchez C; Valls MF; Ruano J; Piñera C; Duran RM
    Transpl Int; 2006 Mar; 19(3):245-8. PubMed ID: 16441775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus as an alternative to anticalcineurin therapy in heart transplantation: experience of a single center.
    Fernandez-Valls M; Gonzalez-Vilchez F; de Prada JA; Ruano J; Ruisanchez C; Martin-Duran R
    Transplant Proc; 2005 Nov; 37(9):4021-3. PubMed ID: 16386615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction.
    Gustafsson F; Ross HJ; Delgado MS; Bernabeo G; Delgado DH
    J Heart Lung Transplant; 2007 Oct; 26(10):998-1003. PubMed ID: 17919619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus experience in heart transplantation.
    Aranda-Dios A; Lage E; Sobrino JM; Mogollón MV; Guisado A; Cabezón S; Hinojosa R; Hernández A; Ordóñez A
    Transplant Proc; 2006 Oct; 38(8):2547-9. PubMed ID: 17097997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation.
    Hunt J; Lerman M; Magee MJ; Dewey TM; Herbert M; Mack MJ
    J Heart Lung Transplant; 2005 Nov; 24(11):1863-7. PubMed ID: 16297793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure.
    González-Vílchez F; de Prada JA; Exposito V; García-Camarero T; Fernández-Friera L; Llano M; Ruano J; Martín-Durán R
    J Heart Lung Transplant; 2008 Oct; 27(10):1135-41. PubMed ID: 18926406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact on renal function of the use of sirolimus in cardiac transplantation.
    Ubilla M; Mastrobuoni S; Cordero A; Castaño S; Herreros J; Rábago G
    Transplant Proc; 2007 Sep; 39(7):2401-2. PubMed ID: 17889202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of sirolimus in heart transplant recipients with chronic renal impairment.
    Moloney ED; O'Mahony U; Kirwan M; McCarthy J; Hurley J; Wood AE; Egan JJ
    Transplant Proc; 2004 Jun; 36(5):1547-50. PubMed ID: 15251382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of chronic renal impairment with sirolimus after lung transplantation.
    Venuta F; De Giacomo T; Rendina EA; Quattrucci S; Mercadante E; Cimino G; Ibrahim M; Diso D; Bachetoni A; Coloni GF
    Ann Thorac Surg; 2004 Dec; 78(6):1940-3. PubMed ID: 15561004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
    Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
    Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC; Srun SW; Wood EG; Belsha CW; Marshall DL; Ferdman BR
    J Heart Lung Transplant; 2006 May; 25(5):518-22. PubMed ID: 16678029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus.
    Bäckman L; Reisaeter AV; Wramner L; Ericzon BG; Salmela K; Brattström C
    Clin Transplant; 2006; 20(3):336-9. PubMed ID: 16824151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
    Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation.
    Campbell MS; Rai J; Kozin E; Bloom RD; Markmann JF; Olthoff KM; Shaked A; Rajender Reddy K
    Clin Transplant; 2007; 21(3):377-84. PubMed ID: 17488388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.
    Yang YJ; Li LX; He Q; Fan H; Jin ZK; Lang R; Kou JT; Li P; Xie DH; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation.
    Stephany BR; Augustine JJ; Krishnamurthi V; Goldfarb DA; Flechner SM; Braun WE; Hricik DE; Dennis VW; Poggio ED
    Transplantation; 2006 Aug; 82(3):368-74. PubMed ID: 16906035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients.
    Potter BJ; Giannetti N; Edwardes MD; Cecere R; Cantarovich M
    Clin Transplant; 2007; 21(3):305-8. PubMed ID: 17488377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of everolimus in improving renal function in long-term heart transplantation.
    Fiocchi R; Iacovoni A; Sebastiani R; Fontana A; Gandolfi L; Gamba A
    Transplant Proc; 2007; 39(6):1967-9. PubMed ID: 17692667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR inhibitors: do they help preserve renal function?
    Moro J; Almenar L; Martínez-Dolz L; Agüero J; Rueda J; Arnau MA; Izquierdo M; Cano O; Sánchez-Lázaro I; Salvador A
    Transplant Proc; 2007 Sep; 39(7):2135-7. PubMed ID: 17889116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.